We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · August 18, 2020

COVID-19 Risk and Increased Hepatic ACE2 Expression in NAFL and Diabetes

Diabetes Care


Additional Info

Diabetes Care
Increased Hepatic ACE2 Expression in NAFL and Diabetes—A Risk for COVID-19 Patients?
Diabetes Care 2020 Aug 04;[EPub Ahead of Print], J Soldo, M Heni, A Königsrainer, HU Häring, AL Birkenfeld, A Peter

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading